The pharmaceuticals, medicinal chemicals, seasonally adjusted index in North Macedonia currently stands at 207.7, which is 8.0 (4.0%) higher than 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in North Macedonia
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to North Macedonia
Pharmaceuticals, medicinal chemicals
More indicators for North Macedonia
North Macedonia Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 207.7 | +8.0 |
| 2023 Q4 | 199.7 | -18.4 |
| 2023 Q3 | 218.1 | +1.9 |
| 2023 Q2 | 216.2 | +19.6 |
| 2023 Q1 | 196.6 | +17.1 |
| 2022 Q4 | 179.5 | +8.7 |
| 2022 Q3 | 170.8 | -6.3 |
| 2022 Q2 | 177.1 | +6.8 |
| 2022 Q1 | 170.3 | +32.2 |
| 2021 Q4 | 138.1 | -8.3 |
| 2021 Q3 | 146.4 | -7.6 |
| 2021 Q2 | 154.0 | +7.6 |
| 2021 Q1 | 146.4 | -7.2 |
| 2020 Q4 | 153.6 | -10.5 |
| 2020 Q3 | 164.1 | -8.6 |
| 2020 Q2 | 172.7 | +9.9 |
| 2020 Q1 | 162.8 | +13.3 |
| 2019 Q4 | 149.5 | +4.4 |
| 2019 Q3 | 145.1 | +8.6 |
| 2019 Q2 | 136.5 | -13.6 |
| 2019 Q1 | 150.1 | +5.4 |
| 2018 Q4 | 144.7 | +9.8 |
| 2018 Q3 | 134.9 | +18.6 |
| 2018 Q2 | 116.3 | -3.5 |
| 2018 Q1 | 119.8 | -6.9 |
| 2017 Q4 | 126.7 | +1.5 |
| 2017 Q3 | 125.2 | +11.5 |
| 2017 Q2 | 113.7 | -8.0 |
| 2017 Q1 | 121.7 | +3.4 |
| 2016 Q4 | 118.3 | 0.0 |
| 2016 Q3 | 118.3 | +11.4 |
| 2016 Q2 | 106.9 | +7.4 |
| 2016 Q1 | 99.5 | +1.6 |
| 2015 Q4 | 97.9 | -2.3 |
| 2015 Q3 | 100.2 | -7.2 |
| 2015 Q2 | 107.4 | +12.8 |
| 2015 Q1 | 94.6 | -1.4 |
| 2014 Q4 | 96.0 | 0.0 |
| 2014 Q3 | 96.0 | -0.2 |
| 2014 Q2 | 96.2 | +2.6 |
| 2014 Q1 | 93.6 | +7.4 |
| 2013 Q4 | 86.2 | -5.2 |
| 2013 Q3 | 91.4 | -1.8 |
| 2013 Q2 | 93.2 | +0.6 |
| 2013 Q1 | 92.6 | -4.4 |
| 2012 Q4 | 97.0 | +2.4 |
| 2012 Q3 | 94.6 | -3.8 |
| 2012 Q2 | 98.4 | +15.9 |
| 2012 Q1 | 82.5 | -9.4 |
| 2011 Q4 | 91.9 | +11.2 |
| 2011 Q3 | 80.7 | -8.7 |
| 2011 Q2 | 89.4 | -0.6 |
| 2011 Q1 | 90.0 | +1.7 |
| 2010 Q4 | 88.3 | +8.9 |
| 2010 Q3 | 79.4 | -4.4 |
| 2010 Q2 | 83.8 | +2.2 |
| 2010 Q1 | 81.6 | -10.4 |
| 2009 Q4 | 92.0 | +7.3 |
| 2009 Q3 | 84.7 | +1.6 |
| 2009 Q2 | 83.1 | -3.5 |
| 2009 Q1 | 86.6 | -26.2 |
| 2008 Q4 | 112.8 | +3.7 |
| 2008 Q3 | 109.1 | +23.5 |
| 2008 Q2 | 85.6 | -0.4 |
| 2008 Q1 | 86.0 | +11.8 |
| 2007 Q4 | 74.2 | -5.2 |
| 2007 Q3 | 79.4 | -3.1 |
| 2007 Q2 | 82.5 | -2.0 |
| 2007 Q1 | 84.5 | +3.9 |
| 2006 Q4 | 80.6 | +2.5 |
| 2006 Q3 | 78.1 | +5.8 |
| 2006 Q2 | 72.3 | -3.9 |
| 2006 Q1 | 76.2 | +4.1 |
| 2005 Q4 | 72.1 | +1.2 |
| 2005 Q3 | 70.9 | -1.1 |
| 2005 Q2 | 72.0 | -6.7 |
| 2005 Q1 | 78.7 |